Aclarion Inc (ACONW) is a transformative healthcare technology company specializing in advanced non-invasive imaging solutions aimed at improving the diagnosis and management of musculoskeletal disorders. By integrating sophisticated data analytics with proprietary algorithms, Aclarion delivers actionable insights that enhance personalized patient care while streamlining clinical workflows. This innovative approach positions the company as a leader in the healthcare diagnostics sector, committed to meeting the evolving needs of both patients and healthcare professionals. As Aclarion continues to expand its market presence, it remains focused on redefining standards in medical imaging through impactful solutions that significantly improve patient outcomes.
| Revenue (TTM) | 77,880 |
| Gross Profit (TTM) | 15,070 |
| EBITDA | $-8.31M |
| Operating Margin | -14129.00% |
| Return on Equity | -45.40% |
| Return on Assets | -28.80% |
| Revenue/Share (TTM) | $0.08 |
| Book Value | $8.04 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.30% |
| Shares Outstanding | 0 |
| Float | $2.20M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting